Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND4 pseudogene 29 (MTND4P29) is a nuclear pseudogene derived from the mitochondrial ND4 gene. It contains sequence homology to the functional mitochondrial MT-ND4 gene but does not encode a functional protein. Instead, its presence reflects past gene duplication events, and it is not involved in mitochondrial electron transport or oxidative phosphorylation. Unlike pathogenic mutations in the real MT-ND4 gene (associated with disorders such as Leber hereditary optic neuropathy), MTND4P29 does not play a direct biological or disease-linked role. In summary, MTND4P29 is a pseudogene and not a bona fide therapeutic target; it should not be confused with the protein-coding MT-ND4 gene. Pseudogenes like MTND4P29 generally lack biochemical activity and clinical relevance as drug targets or biomarkers.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND4 pseudogene 29 (MTND4P29).